Comprehensive Biomarker Testing of Glycemia, Insulin Resistance, and Beta Cell Function Has Greater Sensitivity to Detect Diabetes Risk Than Fasting Glucose and HbA1c and Is Associated with Improved Glycemic Control in Clinical Practice

Blood-based biomarker testing of insulin resistance (IR) and beta cell dysfunction may identify diabetes risk earlier than current glycemia-based approaches. This retrospective cohort study assessed 1,687 US patients at risk for cardiovascular disease (CVD) under routine clinical care with a compreh...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Varvel, Stephen A., Voros, Szilard, Thiselton, Dawn L., Pottala, James V., Dall, Tara, Warnick, G. Russell, McConnell, Joseph P., Ghaedi, Leila, Sasinowski, Maciek, Graham, Timothy
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Springer US 2014
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4137169/
https://ncbi.nlm.nih.gov/pubmed/25070680
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12265-014-9577-1
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia